Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 11, 1997, Pages 3851-3858

  Thomas, T Z ^a   Wang, H ^a   Niclasen, P ^a   O'Bryan, M K ^a   Evans, L W ^c   Groome, N P ^c   Pedersen, J ^b   Risbridger, G P ^a  

^a MONASH UNIVERSITY   (Australia)

^b MELBOURNE PATHOLOGY   (Australia)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; FOLLISTATIN; PROTEIN SUBUNIT;

ALTERNATIVE RNA SPLICING; ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; DIMERIZATION; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN SYNTHESIS INHIBITION; TUMOR GROWTH; TUMOR LOCALIZATION;

EID: 0030726297     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.11.4374     Document Type: Article

References (30)

1. Robertson DM, Foulds LM, Leversha L, et al. 1985 Isolation of inhibin from bovine follicular fluid. Biochem Biophys Res Commun. 126:226-226
2. Rivier C, Rivier J, Vale WW. 1986 Inhibin-mediated feedback control of follicle stimulating hormone secretion in the female rat. Science. 234:205-208.
3. Ling N, Ying S-Y, Ueno N, et al. 1986 Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin. Nature. 321:779-782.
4. Burger HG. 1988 Inhibin: definition and nomenclature including related substances. J Endocrinol. 117:159-160.
5. 1H]thymidine incorporation by rat thymocytes and 3T3 fibroblasts in vitro. Mol Cell Endocrinol. 61:133-138.
6. Mather JP, Attie KM, Woodruff T, Rice GC, Phillips DM. 1990 Activin stimulates spermatogonial proliferation in Germ-Sertoli cell co-cultures from immature rat. Endocrinology. 127:3206-3214.
7. Nakao K, Kosaka M, Saito S. 1991 Effects of erythroid differentiation factor (EDF) on proliferation and differentiation of human haematopoietic progenitors. Exp Hematol. 19:1090-1095.
8. Kojima I, Mogami H, Shibata H. 1993 Activin A inhibits cell-cycle progression induced by inulin-like growth factor I in Balb/c 3T3 cells. J Endocrinol. 137:99-105.
9. Nishihara T, Okahashi N, Ueda N. 1993 Activin A induces apoptotic cell death. Biochem Biophys Res Commun. 197:985-991.
10. Robertson DM, Klein R, de Vos FL, et al. 1987 The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin. Biochem Biophys Res Commun. 149:744-749.
11. Mather JP, Roberts PE, Krummen LA. 1993 Follistatin modulates activin activity in a cell-and tissue-specific manner. Endocrinology. 132:2732-2734.
12. Sugino K, Kurosawa N, Nakamura T, et al. 1993 Molecular heterogeneity of follistatin, an activin-binding protein. J Biol Chem. 268:15579-15587.
13. Thomas TZ, Wang H, Chapman S, et al. Inhibins and activins in men with benign prostatic hyperplasia. Prostate. In press.
14. Ying S-Y, Zhang Z, Xing W. 1995 Expression of activin and activin receptors in PC3 human prostatic tumour cell lines. Int J Oncol. 6:601-606.
15. Batres Y, Zhang Z, Ying S-Y. 1995 Expression of activins and activin receptor messenger RNAs in LNCaP cells, a human prostatic adenocarcinoma cell line. Int J Oncol. 6:1185-1188.
16. Furst BA, Zhang Z, Ying S-Y. 1995 Expression of activin and activin receptors in human prostatic carcinoma cell line DU145. Int J Oncol. 7:239-243.
17. Matzuk MM, Finegold MJ, Su J-GJ, Hseuh AJ, Bradley A. 1992 Alpha inhibin is a tumour suppressive gene with gonadal specificity in mice. Nature. 360:313-319.
18. McPherson SJ, Thomas TZ, Wang H, Gurusinghe CJ, Risbridger GP. 1997 Growth inhibitory response to activin A and B by human prostate tumour cell lines, LNCaP and DU145. J Endocrinol. 154(3):535-545.
19. Roberts V, Meunier H, Sawchenko PE, Vale W. 1991 Differential production of inhibin subunits in rat testicular cell types. Endocrinology. 125:2350-2359.
20. Groome N, Lawrence M. 1991 Preparation of monoclonal antibodies to the beta A subunit of ovarian inhibin using a synthetic peptide immunogen. Hybridoma. 10:309-316.
21. Groome NP, Illingworth PJ, O'Brien M, et al. 1996 Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab. 81:1401-1405.
22. Klein R, Robertson DM, Shukovski L, Findlay JK, de Kretser DM. 1991 The radio-immunoassay of follicle stimulating hormone suppressing protein (FSP): stimulation of bovine granulosa cell FSP secretion by FSH. Endocrinology. 128:1048-1056.
23. Madjic G, McNeilly AS, Sharpe RM, Evans LW, Groome NP. 1997 Testicular expression of inhibin and activin subunits and follistatin in the rat and human foetus and neonate and during postnatal development in the rat. Endocrinology. 138:2136-2147.
24. Esch FS, Shimasaki S, Cooksey K, et al. 1987 Complementary deoxyribonucleic acid (cDNA) cloning and DNA sequence analysis of rat ovarian inhibins. Mol Endocrinol. 1:388-396.
25. Michel U, Albiston A, Findlay JK. 1990 Rat follistatin: Gonadal and extragonadal expression and evidence for alternative splicing. Biochem Biophys Res Commun. 173:401-407.
26. Bonkhoff H, Stein U, Remberger K. 1994 The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate. 24:114-118.
27. Wang QF, Tilly KI, Tilly JL, et al. 1996 Activin inhibits basal and androgen stimulated proliferation and induces apoptosis in the human prostate cancer cell line, LNCaP. Endocrinology. 137:5476-5483.
28. Dalkin AC, Gilrain JT, Bradshaw D, Myers CE. 1996 Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells. Endocrinology. 137:5230-5235.
29. Hseuh AJW, Dahl KD, Vaughan J, et al. 1987 Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of leutenising hormone-stimulated androgen biosynthesis. Proc Natl Acad Sci USA. 84:5082-5086.
30. Markowitz S, Wang J, Myeroff, et al. 1995 Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability. Science. 268:1336-1338.